MEI Pharma, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 03/20/2020   Download
SEC Document
SEC Filing

On March 18, 2020, the Board of Directors of MEI Pharma, Inc. (the “Company”) approved the amendment of the Company’s Second Amended and Restated Bylaws (as so amended, the Company’s bylaws are the Third Amended and Restated Bylaws) to permit its annual meeting of stockholders to be conducted by means of remote communication, effective immediately.